Lab Network Partnerships N-of-One already collaborates with sequencing providers such as Macrogen (now Psomagen) to deliver high-level clinical interpretation for newly launched NGS panels, signaling a sales path to additional labs and contract research organizations for co-sell opportunities and bundled interpretation services.

Clinical Oncology Focus Position as a clinician-focused molecular decision support partner for oncology, helping hospitals and clinics translate complex genomic results into actionable therapy options and potentially upsell expanded panels or interpretation modules.

Strategic Channel Leverage the lean team to pursue channel partnerships with EHR vendors, lab distributors, and CROs to scale reach and integrate decision-support into existing clinical workflows, shortening sales cycles.

Market Fit ROI Market faster time-to-therapy as a clear ROI driver for health systems and payers, using case studies to illustrate improved decision speed and treatment alignment versus standalone data analysis.

Growth Opportunities Historical interest from large genomics players and past Qiagen engagement indicate potential for strategic investment or acquisition to scale capacity, broaden panel coverage, and accelerate market penetration.